Driven by innovation, research, and a deep commitment to social responsibility, Pharmalat has grown from a small, family-run ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with Switzerland-based ...

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...

Discover why pharmaceutical-grade supplements command premium prices and whether their higher standards of purity, potency ...

Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to ...

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

Swiss pharmaceutical giant Novartis will watch "very carefully" how the reciprocal tariff policy proposed by the United ...

We are the problem when we would rather take the injection or the pill than make the lifestyle change. I am fortunate that I ...

Abdul Muktadir, chairman and managing director of Incepta Pharmaceuticals Ltd, has been elected president of the Bangladesh ...

Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho Pharmaceutical") and Araris Biotech AG (hereinafter "Araris"), a Swiss biotechnology company developing next-generation antibody drug conjugates ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...